BackEikon Therapeutics Common Stock Overview

Eikon Therapeutics Common Stock Net Tangible Assets

Track Eikon Therapeutics Common Stock's net tangible assets ($550M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$550.67M

Peer average

Loading

Eikon Therapeutics Common Stock Net Tangible Assets History

Loading

Eikon Therapeutics Common Stock vs. peers: Net Tangible Assets Comparison

Loading

Eikon Therapeutics Common Stock Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eikon Therapeutics Common Stock (EIKN) FAQ

As of the most recent data (March 2026), EIKN shows a net tangible assets of $550M. Scroll down for historical charts and peer comparison views.

Tracking EIKN's net tangible assets over time shows whether Eikon Therapeutics Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $550M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Eikon Therapeutics Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $550M) with ownership activity and broader fundamentals.

Eikon Therapeutics Common Stock's net tangible assets is $550M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.